bnr.nl reported on Sunday that a possible biological connection has been discovered between the drug Ozempic and hair loss in men. The Dutch outlet published the report on 4 October 2026. According to bnr.nl, the finding points to a biological link, though the report does not specify who conducted the research or where it was carried out.
Ozempic is widely known as a treatment for type 2 diabetes that is also used for weight loss. Hair loss has previously been raised as a possible side effect of the drug, and the report from bnr.nl now suggests there may be a biological mechanism behind it in men.
The report offers limited detail. It does not name the researchers, the institution, or the study population, and it does not state whether the work has been peer-reviewed or published in a journal. No figures on how many men were affected, or how severe the hair loss was, are included in the material available.
Because the underlying study has not been described in full, the claim should be treated as preliminary. bnr.nl frames the connection as possible rather than confirmed, and the outlet's report does not indicate that any regulatory body has acted on the finding.
What to watch next: whether the researchers behind the finding publish their data, and whether drug regulators or the manufacturer respond to the reported link.
